CA2893951C - Methods of treating or preventing respiratory conditions - Google Patents
Methods of treating or preventing respiratory conditions Download PDFInfo
- Publication number
- CA2893951C CA2893951C CA2893951A CA2893951A CA2893951C CA 2893951 C CA2893951 C CA 2893951C CA 2893951 A CA2893951 A CA 2893951A CA 2893951 A CA2893951 A CA 2893951A CA 2893951 C CA2893951 C CA 2893951C
- Authority
- CA
- Canada
- Prior art keywords
- stro
- cells
- mpcs
- respiratory condition
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736352P | 2012-12-12 | 2012-12-12 | |
| US61/736,352 | 2012-12-12 | ||
| PCT/AU2013/001454 WO2014089625A1 (en) | 2012-12-12 | 2013-12-12 | Methods of treating or preventing respiratory conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2893951A1 CA2893951A1 (en) | 2014-06-19 |
| CA2893951C true CA2893951C (en) | 2022-05-03 |
Family
ID=50933587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2893951A Active CA2893951C (en) | 2012-12-12 | 2013-12-12 | Methods of treating or preventing respiratory conditions |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10028979B2 (enExample) |
| EP (1) | EP2931373B1 (enExample) |
| JP (5) | JP6313327B2 (enExample) |
| KR (1) | KR101748712B1 (enExample) |
| CN (2) | CN115919901A (enExample) |
| AU (4) | AU2013360026B2 (enExample) |
| CA (1) | CA2893951C (enExample) |
| ES (1) | ES2759281T3 (enExample) |
| IL (1) | IL239309A0 (enExample) |
| SG (2) | SG10201807682PA (enExample) |
| WO (1) | WO2014089625A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2893951C (en) | 2012-12-12 | 2022-05-03 | Mesoblast, Inc. | Methods of treating or preventing respiratory conditions |
| US20170296589A1 (en) * | 2014-09-23 | 2017-10-19 | Case Western Reserve University | Compositions and methods for treating lung remodeling diseases |
| WO2019051536A1 (en) * | 2017-09-15 | 2019-03-21 | Cynata Therapeutics Limited | METHOD OF TREATING ALLERGIC RESPIRATORY TRACT DISEASE (DAA) / ASTHMA |
| EP4098267A4 (en) * | 2020-01-30 | 2024-03-06 | JCR Pharmaceuticals Co., Ltd. | MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP |
| JP7551341B2 (ja) * | 2020-06-04 | 2024-09-17 | 株式会社三共 | 遊技機 |
| JP7551340B2 (ja) * | 2020-06-04 | 2024-09-17 | 株式会社三共 | 遊技機 |
| CN118800458B (zh) * | 2024-09-14 | 2024-11-15 | 吉林大学 | 一种心胸外科术后并发症预测方法及系统 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| AU2003207399A1 (en) * | 2002-02-19 | 2003-09-09 | Medipost Co., Ltd. | Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues |
| US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| TR201900968T4 (tr) * | 2004-09-24 | 2019-02-21 | Mesoblast Inc | Multipotansiyel genleşmiş mezenkimal prekürsör hücre soyu (memp) ve bunların kullanımı. |
| US8367405B2 (en) * | 2005-04-12 | 2013-02-05 | Mesoblast, Inc. | Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| US20120269774A1 (en) | 2006-09-21 | 2012-10-25 | Medistem Laboratories, Inc | Allogeneic stem cell transplants in non-conditioned recipients |
| US20090053182A1 (en) * | 2007-05-25 | 2009-02-26 | Medistem Laboratories, Inc. | Endometrial stem cells and methods of making and using same |
| CN103169731A (zh) * | 2007-08-06 | 2013-06-26 | 成血管细胞系统公司 | 用于体内生成、修复和/或维护结缔组织的方法 |
| ES2595103T3 (es) * | 2007-10-17 | 2016-12-27 | Txcell | Células Tr1, células madre mesenquimales y usos de estas |
| SG193888A1 (en) * | 2008-09-03 | 2013-10-30 | Mesoblast Inc | Expansion of haemopoietic precursors |
| KR101871472B1 (ko) * | 2010-07-02 | 2018-06-27 | 메소블라스트, 아이엔씨. | 이식편대숙주 질환의 치료 방법 |
| KR102063069B1 (ko) * | 2011-03-11 | 2020-01-08 | 칠드런'즈 메디컬 센터 코포레이션 | 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물 |
| EP2714057B1 (en) * | 2011-06-03 | 2019-11-06 | Mesoblast, Inc. | Methods of treating or preventing neurological diseases |
| CA2893951C (en) | 2012-12-12 | 2022-05-03 | Mesoblast, Inc. | Methods of treating or preventing respiratory conditions |
-
2013
- 2013-12-12 CA CA2893951A patent/CA2893951C/en active Active
- 2013-12-12 CN CN202310100395.1A patent/CN115919901A/zh active Pending
- 2013-12-12 EP EP13862590.0A patent/EP2931373B1/en active Active
- 2013-12-12 KR KR1020157017530A patent/KR101748712B1/ko active Active
- 2013-12-12 SG SG10201807682PA patent/SG10201807682PA/en unknown
- 2013-12-12 SG SG11201504352TA patent/SG11201504352TA/en unknown
- 2013-12-12 AU AU2013360026A patent/AU2013360026B2/en active Active
- 2013-12-12 JP JP2015546771A patent/JP6313327B2/ja active Active
- 2013-12-12 ES ES13862590T patent/ES2759281T3/es active Active
- 2013-12-12 CN CN201380072492.9A patent/CN105377274A/zh active Pending
- 2013-12-12 US US14/650,171 patent/US10028979B2/en active Active
- 2013-12-12 WO PCT/AU2013/001454 patent/WO2014089625A1/en not_active Ceased
-
2015
- 2015-06-09 IL IL239309A patent/IL239309A0/en unknown
-
2018
- 2018-03-22 JP JP2018055386A patent/JP6665218B2/ja active Active
- 2018-07-16 US US16/036,402 patent/US10688134B2/en active Active
- 2018-09-10 AU AU2018226514A patent/AU2018226514B2/en active Active
-
2020
- 2020-02-19 JP JP2020026138A patent/JP2020097618A/ja active Pending
- 2020-03-20 AU AU2020202022A patent/AU2020202022A1/en not_active Abandoned
- 2020-06-01 US US16/889,354 patent/US20200289578A1/en not_active Abandoned
-
2022
- 2022-02-18 JP JP2022024306A patent/JP7420844B2/ja active Active
- 2022-07-26 AU AU2022209219A patent/AU2022209219B2/en active Active
-
2024
- 2024-01-11 JP JP2024002878A patent/JP2024041904A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018226514B2 (en) | Methods of treating or preventing respiratory conditions | |
| US20190201448A1 (en) | Methods of treating or preventing neurological diseases | |
| AU2019202960A1 (en) | Treatment of diseases of endothelial dysfunction and inflammation | |
| AU2016247132B2 (en) | Methods for treating obesity and/or metabolic syndrome | |
| US20240024366A1 (en) | Methods of treating or preventing respiratory conditions | |
| HK1210077B (en) | Methods of treating or preventing respiratory conditions | |
| HK1210209B (en) | Treatment of diseases of endothelial dysfunction and inflammation | |
| HK40014520A (en) | Treatment of diseases of endothelial dysfunction and inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20181122 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD Year of fee payment: 11 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241122 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241122 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241122 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD Year of fee payment: 12 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251023 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251023 |